Abstract
Because of the evidence for the involvement of xenobiotic bioactivation in pulmonary toxicity and carcinogenesis, it is important to improve our understanding of the xenobiotic-metabolizing enzymes in isolated and cultured specific pulmonary cell populations. Some phase I and phase II xenobiotic-metabolizing enzyme activities, reduced glutathione (GSH), and γ-glutamyl transferase (γ-GT) were studied in rat type II pneumocytes and alveolar macrophages cultured for up to 48 h and 3 h, respectively. In type II pneumocytes, 7-ethoxyresorufin activity was not detected. 7-Benzyloxyresorufin (BROD) and 7-pentoxyresorufin (PROD) O-dealkylation decreased at 24 h by 84 and 82%, respectively, and continued to decline over the next 24 h with no measurable PROD at 48 h. The activity of NADPH- and NADH-cytochrome c reductase at 48 h decreased by 31 and 67%, respectively. GST activity decreased by 25 and 42% at 24 and 48 h, respectively. A transient increase in DT-diaphorase activity was observed at 24 h (by 55%). GSH content and γ-GT activity increased significantly with time in culture. In freshly isolated alveolar macrophages, BROD activity was the only cytochrome P450-dependent alkoxyresorufin-O-dealkylase activity measured. BROD activity decreased by 38% in 3-h-attached macrophages. There were no changes in NADPH- and NADH-cytochrome c reductase, GST, and DT-diaphorase. An increase of GSH (by 24%) was observed in attached macrophages. In conclusion, type II pneumocytes and to a lesser extent alveolar macrophages in primary cultures undergo changes in biotransformation-related enzyme activities and intracellular GSH level that may affect xenobiotic toxicity at different times in culture.
Footnotes
-
This work was supported by a fellowship from the European Respiratory Society to S. Dimova and partly by INCO/Copernicus (EU) (IC15-CT96-0314). This work was partly presented at the 39th Annual Meeting of the Society of Toxicology, Philadelphia, March 19–23, 2000, Abstract in Toxicol Sci (2000) 54 (Suppl):19.
- Abbreviations used are::
- CYP
- cytochrome P450
- GSH
- reduced glutathione
- DMEM
- Dulbecco's modified Eagle's medium
- FBS
- fetal bovine serum
- BROD
- 7-benzyloxyresorufinO-dealkylation
- PROD
- 7-pentoxyresorufinO-dealkylation
- EROD
- 7-ethoxyresorufinO-dealkylation
- GST
- glutathioneS-transferase
- γ-GT
- γ-glutamyl transferase
- ANOVA
- analysis of variance
- Received April 4, 2001.
- Accepted July 6, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|